|
End-of-day quote
Shanghai S.E.
11/09/2026
|
5-day change | 1st Jan Change | ||
| 14.02 CNY | -0.85% |
|
-4.82% | -6.97% |
| 02/09 | CICC Starts Tasly Pharmaceutical Group at Outperform with 17.80 Yuan Price Target | MT |
| 24/08 | Tasly Pharmaceutical to Buy 4 Billion Yuan of Wealth Management Products | MT |
| Market Cap | 20.95B 3.12B 2.69B 2.55B 2.31B 4.33B 298B 4.35B 30.25B 11.63B 152B 11.73B 11.47B 480B | P/E 2026 * |
15.7x | P/E 2027 * | 13.2x |
|---|---|---|---|---|---|
| Enterprise Value | 19.4B 2.89B 2.49B 2.36B 2.14B 4.01B 276B 4.03B 28.02B 10.78B 141B 10.86B 10.62B 444B | EV / Sales 2026 * |
2.25x | EV / Sales 2027 * | 1.63x |
| Free-Float |
47.11% | Yield 2026 * |
2.77% | Yield 2027 * | 3.36% |
| 1 day | -0.85% | ||
| 1 week | -4.82% | ||
| Current month | -4.50% | ||
| 1 month | -9.72% | ||
| 3 months | -1.27% | ||
| 6 months | -2.23% | ||
| Current year | -6.97% |
| 1 week | 13.78 |  | 14.87 |
| 1 month | 13.78 | | 15.61 |
| Current year | 12.9 | | 16.24 |
| 1 year | 12.9 | | 16.5 |
| 3 years | 12.24 | | 18 |
| 5 years | 9.2 | | 18 |
| 10 years | 9.2 | | 34.22 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jin Yong Cai
CEO | Chief Executive Officer | 54 | 08/05/2024 |
Jie Wei
DFI | Director of Finance/CFO | 49 | 09/07/2018 |
Xin Yang
CIO | Chief Investment Officer | 45 | 01/05/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Ai Jian Wang
BRD | Director/Board Member | 72 | 02/06/2021 |
Jin Yong Cai
CHM | Chairman | 54 | 10/08/2026 |
Ke Xin Li
BRD | Director/Board Member | 58 | 08/05/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.85% | -4.82% | -13.88% | +3.32% | 3.12B | |
| 0.00% | -1.22% | -15.75% | -5.26% | 13.4B | |
| -1.27% | -3.07% | -33.84% | -57.38% | 4.78B | |
| -0.61% | -5.58% | -6.56% | -5.17% | 4.36B | |
| -1.49% | -4.28% | -12.85% | -32.25% | 3.78B | |
| -2.78% | -3.65% | -4.76% | -4.98% | 3.41B | |
| -1.37% | -3.98% | -25.63% | +0.91% | 3.43B | |
| -1.30% | -2.63% | -25.16% | -18.35% | 2.27B | |
| -2.13% | -2.81% | -30.61% | -19.18% | 1.63B | |
| -2.31% | -3.87% | -7.05% | -19.00% | 1.6B | |
| Average | -1.41% | -2.92% | -17.61% | -15.74% | 4.18B | |
| Weighted average by Cap. | -0.99% | -2.31% | -17.13% | -14.27% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 8.63B 1.29B 1.11B 1.05B 952M 1.79B 123B 1.79B 12.47B 4.8B 62.55B 4.83B 4.73B 198B | 9.36B 1.39B 1.2B 1.14B 1.03B 1.93B 133B 1.94B 13.51B 5.2B 67.79B 5.24B 5.12B 214B |
| Net income | 1.34B 199M 172M 163M 147M 277M 19.04B 278M 1.93B 743M 9.69B 749M 732M 30.61B | 1.58B 236M 203M 192M 174M 327M 22.5B 328M 2.28B 878M 11.45B 885M 865M 36.18B |
| Net Debt | -1.54B -230M -198M -188M -170M -319M -21.99B -321M -2.23B -857M -11.19B -864M -845M -35.34B | -5.71B -851M -734M -695M -630M -1.18B -81.34B -1.19B -8.25B -3.17B -41.38B -3.2B -3.13B -131B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/09/26 | CNY 14.02 | -0.85% | 21,057,925 |
| 10/09/26 | CNY 14.14 | -1.74% | 10,971,603 |
| 09/09/26 | CNY 14.39 | -1.10% | 12,817,880 |
| 08/09/26 | CNY 14.55 | -0.48% | 10,011,300 |
| 07/09/26 | CNY 14.62 | -0.75% | 11,047,854 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 600535 Stock
Select your edition
All financial news and data tailored to specific country editions
